Innovation in Oncology Drug Development

Table 1

Illustration of new cancer diagnosis and 5-year survival rates of different cancer types in the US [1].

Cancer type	Estimated new cases in 2016	Estimated 5-year relative survival rate in 2016
Testis	8,720	95%
Thyroid	64,300	98%
Melanoma	76,380	98% if localized; 17% if advanced
Pancreas	53,070	7%
Liver and bile duct	39,230	17%
Lung and bronchus	224,390	17%
Esophagus	16,910	18%
Gallbladder	11,420	18%
Gastric	26,370	26%
Acute myeloid leukemia	19,950	26%
Brain	23,770	29%